¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¼Ö·ç¼Çº°, Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Immunomodulators Market Size, Share & Trends Analysis Report By Solution, By Product (Immunosuppressants, Immunostimulants), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1553451
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 3¾ï 2,980¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.2%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº À¯¸í ±â¾÷µéÀÇ °í¾× R&D ÅõÀÚ°¡ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â Ä¡·á È¿°ú°¡ ¶Ù¾î³­ ½Å¾àÀÇ ´ë·® »ý»êÀ¸·Î À̾îÁú °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÀÌ¿¡ µû¶ó ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå¿¡´Â Àü·Ê ¾ø´Â ¼Óµµ·Î ¾à¹°ÀÌ À¯ÀÔµÇ¾î ¸¹Àº ÀÚ°¡¸é¿ªÁúȯ ¹× ¿°Áõ¼º Áúȯ¿¡ ´ëÇÑ ¸Å¿ì È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¾à¹° ³»¼º Áõ°¡·Î ÀÎÇØ Ç¥Àû Ä¡·á ¸ÞÄ¿´ÏÁòÀ» °¡Áø Â÷¼¼´ë ¸é¿ªÁ¶ÀýÁ¦ °³¹ß¿¡ ´ëÇÑ ÀÓ»óÀû ½Ã±Þ¼ºÀÌ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀÇ ºü¸¥ ¼ºÀåÀ¸·Î ȯÀÚ»Ó¸¸ ¾Æ´Ï¶ó ÀÇ»çµé »çÀÌ¿¡¼­µµ ¸é¿ªÁ¶ÀýÁ¦ÀÇ À¯¿ë¼º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ¸é¿ªÁ¶ÀýÁ¦ »ê¾÷ÀÇ ¼ºÀå ÀáÀç·ÂÀ» ´õ¿í È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ´Ù¹ß¼º °æÈ­Áõ, Å©·Ðº´, ·ù¸¶Æ¼½º °üÀý¿°, ºñÈ£ÁöŲ ¸²ÇÁÁ¾ µî ´Ù¾çÇÑ ÀûÀÀÁõ¿¡ ´ëÇÑ ´ÜŬ·ÐÇ×üÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϸ鼭 ¿¹Ãø ±â°£ µ¿¾È ¸é¿ªÁ¶ÀýÁ¦ »ê¾÷À» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÚ°¡¸é¿ªÁúȯ¿¡¼­ ¸Å¿ì Áß¿äÇÑ ´ÜŬ·ÐÇ×üÀÇ ÀϰüµÈ Á¦Ç° ½ÂÀÎ °Ç¼ö´Â ¼ºÀå ¹üÀ§¸¦ È®´ëÇÏ´Â ¿äÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¼¼°èÀÇ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¼¼°èÀÇ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¼¼°èÀÇ ¸é¿ªÁ¶ÀýÁ¦ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Immunomodulators Market Growth & Trends:

The global immunomodulators market size is expected to reach USD 329.8 million by 2030, expanding at a CAGR of 6.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to be predominantly driven by high R&D investments employed by prominent companies, resulting in the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedented rate into the immunomodulators market hence providing highly efficacious treatment alternatives for numerous autoimmune and inflammatory diseases.

In addition, increasing drug resistance is predicted to be responsible for boosting the clinical urgency to develop potentially new generation immunomodulators with targeted therapy mechanisms. The aforementioned factors cumulatively are expected to present significant growth opportunities over the forecast period.

Furthermore, the burgeoning presence of the key players is expected to promote the awareness levels pertaining to the benefits of immunomodulators amongst the patients as well as the physicians. This is further expected to widen the immunomodulators industry growth potential during the forecast period.

In addition, increasing adoption of monoclonal antibodies for a wide range of indications, such as, multiple sclerosis, Crohn's disease, rheumatoid arthritis, and Non-Hodgkin's Lymphoma, which is expected to boost immunomodulators industry over the forecast period. The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth.

Immunomodulators Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Global Immunomodulators Market Variables, Trends, & Scope

Chapter 4. Global Immunomodulators Market: Product Estimates & Trend Analysis

Chapter 5. Global Immunomodulators Market: Application Estimates & Trend Analysis

Chapter 6. Global Immunomodulators Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â